Skip to main content
. 2024 Oct 1;10(21):e38826. doi: 10.1016/j.heliyon.2024.e38826

Table 1.

Summary of the features of currently available methods for CNV detection.

Platform resolution TAT(days) Alterations Analytical method Advantage Disadvantage Ref
Karyotyping 5~10 Mb 2~21 CNV, SV Qualitative A gold standard Highly dependent on the expertise of technicians and cytogeneticists [59]
FISH 80–200 kb 3~5 CNV, SV Qualitative A gold standard that serves as a means of verification of known tumor sites Expensive, customization limited by the types of genomic variation, depending on subjective assessment [37,38]
CMA 20–100 kb 3~14 CNV, LOH Quantitative Cost-effective, significant advantages in detecting genomic variations greater than 100 Kb, Limited by the types of genomic variation and the use of hybridization-based assays in repeat-rich and duplicated regions [40,60,61]
CNV-seq ~100 kb 5~14 CNV, SV, LOH, SNV, Indel Quantitative High throughput, excellent compatibility, enabling the detection of large fragments of CNVs at a whole-genome scale. Cannot detect ROH [62]
WGS ≥1 bp 5~14 CNV, SV, LOH, SNV, Indel Quantitative High throughput, comprehensive evaluation of all tumor variation information Expensive, long turnaround time, heavy computational requirements [63]
WES ≥1 bp 5~14 CNV, SV, LOH, SNV, Indel Quantitative High throughput, cost-efficient, and analytic-effective manner Cannot detect pathogenic CNVs located within non-coding regions associated with human disease [64]
dPCR ≥1 bp 2~5 CNV, SV, LOH, SNV, Indel Absolute quantification Higher accuracy and reproducibility Limited or biased by a probe design [65,66]

Abbreviations: CNV, copy number variations; SV, structural variants; FISH, fluorescence in situ hybridization; CMA, CNV microarrays; LOH, loss of heterozygosity; ROH, runs of homozygosity; SNV, single nucleotide variants; WGS,whole genomic sequencing; WES, whole exome sequencing; dRCR, droplet PCR.